Price (delayed)

$33.81

Market cap

$1.57B

P/E Ratio

80.5

Dividend/share

$0.04

EPS

$0.42

Enterprise value

$1.82B

Core Laboratories N V's EPS has soared by 140% YoY and by 119% from the previous quarter

CLB's net income has soared by 140% year-on-year and by 119% since the previous quarter

The stock's price to earnings (P/E) is 53% more than its 5-year quarterly average of 52.5

CLB's gross profit is down by 41% year-on-year and by 12% since the previous quarter

What are the main financial stats of CLB

Market
Valuations
Earnings

Shares outstanding

46.31M

Market cap

$1.57B

Enterprise value

$1.82B

Price to earnings (P/E)

80.5

Price to book (P/B)

10.62

Price to sales (P/S)

3.45

EV/EBIT

42.05

EV/EBITDA

28.61

EV/Sales

4.1

Revenue

$443.25M

EBIT

$43.21M

EBITDA

$63.5M

Free cash flow

$33.97M

Per share
Balance sheet
Liquidity

EPS

$0.42

Free cash flow per share

$0.75

Book value per share

$3.18

Revenue per share

$9.81

TBVPS

$10.55

Total assets

$584.45M

Total liabilities

$438.4M

Debt

$279.16M

Equity

$141.88M

Working capital

$100.28M

Debt to equity

1.97

Current ratio

2.17

Quick ratio

1.34

Net debt/EBITDA

3.96

Margins
Efficiency
Dividend

EBITDA margin

14.3%

Gross margin

22.4%

Net margin

4.3%

Operating margin

9.9%

Return on assets

3.2%

Return on equity

22%

Return on invested capital

6.4%

Return on capital employed

8.7%

Return on sales

9.7%

Dividend yield

0.12%

DPS

$0.04

Payout ratio

9.5%

How has the Core Laboratories N V stock price performed over time

Intraday

6.19%

1 week

19.98%

1 month

19.68%

1 year

107.55%

YTD

27.54%

QTD

17.44%

How have Core Laboratories N V's revenue and profit performed over time

Revenue

$443.25M

Gross profit

$99.46M

Operating income

$43.79M

Net income

$18.89M

Gross margin

22.4%

Net margin

4.3%

The operating margin has soared by 163% from the previous quarter

CLB's net margin has soared by 160% YoY and by 122% from the previous quarter

Core Laboratories N V's operating income has surged by 157% QoQ

CLB's net income has soared by 140% year-on-year and by 119% since the previous quarter

What is Core Laboratories N V's growth rate over time

What is Core Laboratories N V stock price valuation

P/E

80.5

P/B

10.62

P/S

3.45

EV/EBIT

42.05

EV/EBITDA

28.61

EV/Sales

4.1

Core Laboratories N V's EPS has soared by 140% YoY and by 119% from the previous quarter

The stock's price to earnings (P/E) is 53% more than its 5-year quarterly average of 52.5

CLB's equity has soared by 116% YoY and by 98% from the previous quarter

The P/B is 53% below the 5-year quarterly average of 22.5 and 15% below the last 4 quarters average of 12.5

CLB's price to sales (P/S) is 73% higher than its last 4 quarters average of 2.0 but 34% lower than its 5-year quarterly average of 5.2

The company's revenue fell by 32% YoY and by 9% QoQ

How efficient is Core Laboratories N V business performance

The return on equity has surged by 173% year-on-year and by 115% since the previous quarter

Core Laboratories N V's ROS has soared by 161% from the previous quarter

The return on invested capital has surged by 159% since the previous quarter

The ROA has soared by 151% YoY and by 120% from the previous quarter

What is CLB's dividend history

DPS

$0.04

Dividend yield

0.12%

Payout ratio

9.5%

Recent dividends

How did Core Laboratories N V financials performed over time

The total assets is 33% greater than the total liabilities

The quick ratio has increased by 24% QoQ and by 3.1% YoY

The total liabilities has decreased by 24% YoY and by 11% from the previous quarter

CLB's debt is 97% more than its equity

CLB's equity has soared by 116% YoY and by 98% from the previous quarter

The debt to equity has shrunk by 65% YoY and by 57% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.